Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events
July 31, 2018 16:07 ET
|
Geron Corporation
MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, 2018. Second Quarter and Year to...
Geron Announces Oral Presentation at European Hematology Association Congress
May 17, 2018 09:05 ET
|
Geron Corporation
MENLO PARK, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that an abstract describing clinical data regarding the telomerase inhibitor imetelstat has been...
Geron 2018 Annual Meeting of Stockholders to be Held on May 15
April 17, 2018 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018, at 4:00 p.m. PDT. Geron’s...
Geron to Present at the Needham Healthcare Conference
March 21, 2018 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events
March 16, 2018 16:10 ET
|
Geron Corporation
MENLO PARK, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results
February 22, 2018 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017, on Friday, March...
Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
December 12, 2017 07:30 ET
|
Geron Corporation
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif., Dec. ...
Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017
December 06, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the company’s analyst and investor meeting to discuss imetelstat clinical data will take...
Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
November 20, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3...
Geron Announces November Investor Conference Presentation Webcasts
November 07, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...